The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer.
Andrew Szehsun Chiang
No relevant relationships to disclose
D. Andrew Loblaw
No relevant relationships to disclose
Vibhuti Jethava
No relevant relationships to disclose
Perakaa Sethukavalan
No relevant relationships to disclose
Liying Zhang
No relevant relationships to disclose
Danny Vesprini
No relevant relationships to disclose
Alexandre Mamedov
No relevant relationships to disclose
Robert Nam
No relevant relationships to disclose
Laurence Klotz
No relevant relationships to disclose